1,4‐Naphthoquinone Analogs and Their Application as Antibacterial Agents

Abstract Antimicrobial resistance threatens the effective prevention and treatment of an ever‐increasing range of infections caused by different types of bacteria. Addressing antibacterial resistance and protecting human health requires multi‐sectoral, long‐acting, and professional administration. Sustainable investment in the R&D of antimicrobial drugs is one of the critical strategies for solving the current problem. Specifically, the development of novel effective drug candidates with a unique mode of action is essential for overcoming antibacterial resistance. 1,4‐Naphthoquinone is a quinone derivative from naphthalene, one of the most important subclasses of quinone. 1,4‐Naphthoquinones have been studied as potential candidates against various diseases, including cancer and malaria, and are a promising new compound that can treat bacterial infections. This review focuses on 1,4‐naphthoquinone analogs for their activity against bacteria.